The Likvor CELDA™ System is the first commercial instrument for better diagnostics of idiopathic Normal Pressure Hydrocephalus (iNPH or NPH). Through automated and standardised protocols the Likvor CELDA System assess the cerebrospinal fluid system (CFS) dynamics, helping caregivers to make the correct diagnosis for suspected iNPH patients in shorter time.
Likvor cooperates with Geras Solutions, which has digital tools for better investigation and care in cognitive illness. They shorten the time for the cognitive investigation process and at the same time gain access to a much better basis for decision-making. Read more about Geras Solutions here
Likvor CELDA™️ System sets a new standard for diagnostics of disease linked to disturbances in the cerebrospinal fluid system, such as normal pressure hydrocephalus (NPH). Using automated test protocols and standardised data the Likvor CELDA System enhances care givers ability to include or exclude NPH from the diagnosis. NPH are often mistaken for other neurological diseases such as Parkinson’s and Alzheimer’s, making a correct and objective assessments a high priority.
Following a shunt implant operation the Likvor CELDA™ System makes it easy to assess the CSF dynamics and observe the functionality of the shunt device. The CELDA Instrument lets you evaluate whether unchanged or worsened symptoms can be corrected by shunt adjustment and also to discover any cases of shunt dysfunction requiring surgical shunt revision.
Idiopathic normal pressure hydrocephalus, or iNPH, is an accumulation of cerebrospinal fluid, CSF, causing the ventricles of the brain to enlarge. Only 20% of iNPH patients are diagnosed and 15% get the correct treatment. When iNPH is suspected or if there is a need to exclude iNPH, this is the start of the usage of CELDA™️. Evidence before the CELDA™️ investigation include enlarged ventricles, and the triad of cardinal symptoms of NPH which include difficulty in balance and walking, dementia or cognitive impairment and urinary incontinence. Read more »
In 2005, guidelines for iNPH were published. In connection with this, a scheme was presented to show shunt-responsive normal pressure hydrocephalus pressure hydrocephalus on the basis of evidentiary tables.
The degree of certainty in the decision data based on the tests performed are in percent, far left. The red square marks what is included in an infusion test. The software for CELDA Instruments includes both tap tests, bolus tests if desired and CSF dynamics tests for a longer period of time, where all additions of tests contribute to improved prediction of whether a patient is helped by a shunt.
Please consult with us to find the best way to implement the Likvor CELDA™ System in your operations. The instrument and tools are available for immediate delivery.
For units that provide frequent CSF examinations purchasing the CELDA System is a preferred option.
Eliminate the initial purchase cost and pay only per investigation, with a contracted annual minimum.
A complete service option where Likvor provide equipment and a trained operator that perform the examinations.